Skip to main content
Premium Trial:

Request an Annual Quote

ABI to Co-Develop Olink's PLA Technology to Enable Protein Quantitation on RT-PCR Platform

NEW YORK (GenomeWeb News) - Applied Biosystems said today that it will co-develop and commercialize Olink Bioscience's proximity ligation assay technology under an exclusive license.
ABI said the agreement gives it the right to commercialize the PLA technology for “specific applications” in the life science research market, including biomarker validation and characterization of biological processes.
Olink retains the rights to other applications of the technology, including in situ applications in the life science research market and all rights in the area of in vitro diagnostics.
Under the agreement, ABI will develop products for in vitro PLA applications in a controlled environment. These products will combine PLA’s protein-detection capabilities with ABI’s real-time PCR systems in order to enable protein expression studies using the same instruments and reagents that are typically used for genotyping and gene expression analysis, the company said.
PLA uses two oligonucleotide-labeled antibodies, DNA ligation, and nucleic acid amplification to detect proteins, their modifications, and their interactions in limited samples.
The combined technology will allow researchers to correlate gene expression and protein quantitation on the same platform, ABI said.
Financial terms of the agreement were not released.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.